Abstract
We describe the case of a patient with a prior history of acute intermittent porphyria (AIP) who needed the administration of anticancer drugs. Our experience with this patient and the limited experience reported in the literature show that it is probably safe to administer some chemotherapeutic agents, but it is important to prevent (or to minimize) the toxicities of these chemotherapeutic agents, as they seem to put the patient at major risk of an AIP crisis. Hematin and supportive treatments were useful treatments in our patient.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Additional information
Electronic Publication
Rights and permissions
About this article
Cite this article
Forget, F., Awada, A. & Klastersky, J. Anticancer chemotherapy in a patient with prior history of acute intermittent porphyria. Support Care Cancer 9, 465–466 (2001). https://doi.org/10.1007/s005200000232
Published:
Issue Date:
DOI: https://doi.org/10.1007/s005200000232